Home > Healthcare > Medical Devices > Surgical Devices > Endoscopic Submucosal Dissection Market

Endoscopic Submucosal Dissection Market Trends

Report ID: GMI7139
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Endoscopic Submucosal Dissection Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as, growing application in early cancer diagnostics and treatment, increased emphasis on infection control, and rising demand for minimally invasive procedures.

ESD is increasingly used for the early detection and treatment of gastrointestinal cancers, including esophageal, gastric, and colorectal cancers. This trend is driven by the desire to diagnose and treat cancers at an earlier stage, improving patient outcomes.
Moreover, technological advancements, such as the development of more sophisticated endotherapy devices and instruments, continue to benefit ESD. Furthermore, high-definition imaging systems, improved electrosurgical blades, and specialized accessories all contribute to increase accuracy and safety during endoscopic submucosal dissection treatments.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Endoscopic submucosal dissection industry reached USD 333.6 million in revenue in 2022 and is estimated to record USD 629.4 million by 2032 owing to rising incidence of gastrointestinal diseases and the higher demand for minimally invasive procedures.

The stomach cancer application segment held over 63% of the market share in 2022 due to the surging need for minimally invasive procedure for the removal of cancerous lesions without the need for open surgery.

North America endoscopic submucosal dissection industry size was USD 148.4 million in 2022 and is predicted to witness substantial growth through 2032 driven by the presence of well-developed and technologically advanced healthcare infrastructure in the region.

FUJIFILM Holdings Corporation, Ovesco Endoscopy AG, Micro-Tech Endoscopy, Zeon Medical Inc., Cook Medical, Leo Medical Co., Ltd., and Boston Scientific Corporation are some of the leading endoscopic submucosal dissection companies.